$5.70 -0.14 (-2.40%)
11/25/2009 4:00 PM

ZymoGenetics, Inc. (ZGEN)

CAPS Rating: 3 out of 5

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Featured Broker Partners